Over 75,000 Cases Of Artificial Tears, Eye Care Products Recalled
You may want to shed some tears for this recall. Some artificial tears that it. BRS Analytical Service, a pharmaceutical testing lab, is voluntarily recalling over 75,000 cases of eye care products, including various types of artificial tears, according to a U.S. Food and Drug Administration enforcement report. This recall was also announced by AvKare, which distributed these products.
This recall affects lots of eye care products. Namely, over 10 lots of five different products:
So, if you recognize any of the above products, check their lot numbers and expiry dates. Don't just say, 'I'm going to put this in my eye anyway.' If your product is affected by the recall, return it for a refund or discard it immediately. And discard it doesn't mean discard it into your roommate's eyes, no matter what you think about your roommate.
BRS Analytical Service initiated the recall after an FDA audit of the company found a number of deviations from Current Good Manufacturing Practice or cGMP. In this case, cGMP refers to the different things that pharmaceutical manufacturers should do to help ensure that their products have the right amount of purity, quality and safety. This includes procedures to make sure that the products are really, you know, what they are supposed to be.
cGMP encompasses stuff ranging from the design of the products and manufacturing systems to checking the products that result. So that means things like getting the right raw materials for the products, putting in place strong quality management systems, making sure that the operations are robust and properly testing the products so that any deviations can be quickly detected before items are shipped. .
The FDA did not specify what cGMP was not being followed. However, the FDA enforcement report did indicate that the recall was 'due to a lack of assurance to sterility.' In this case, or in these many cases of eye products, 'sterility' presumably doesn't refer to the eye products ability to reproduce. Instead, sterility means being free from biological contaminants.
Getting stuff like bacteria, viruses, fungi or parasites into your eyes can lead to a real eye caramba situation. I've written previously in Forbes about how tainted eye drops have led to deaths and eyeballs removed You can get infections and resulting inflammation of different parts of your eye such as:
Finally, you know how they say the eyes are the window to your soul. They are also windows to other parts of your body. Your eyes are highly vascularized, meaning that they have a good blood supply, because it help for the eyes to get oxygen so that you can do stuff like see. Therefore, any microbe that goes into your eyes could travel via the blood stream to other parts of your body.
So if you've got any artificial tears or other eye care products, check their packages. Make sure that they aren't part of the recall. Unless you happen to be a scallop, you probably have no more than two eyes and want to protect them.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Veradigm Amends and Extends Stockholder Rights Plan
CHICAGO, August 20, 2025--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires beneficial ownership of 20% or more of the outstanding shares of Company common stock (including in the form of synthetic ownership through derivative positions) in a transaction not approved by the Board, whether or not such person or group is an eligible passive investor. The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Rights Plan continue to be present. Accordingly, the Rights Plan is being extended to continue to ensure that all Veradigm stockholders have the opportunity to realize the full potential value of their investment. The Rights Plan does not prevent the Company from pursuing any offer that is fair and otherwise in the best interests of stockholders. The Board currently intends to terminate the Rights Plan no later than the time that the Company becomes current in its financial reporting and has applied for relisting of its shares of common stock on a national stock exchange, which is expected to occur in 2026. Further details about the Rights Plan, as amended, will be contained in a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission. About Veradigm® Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube. © 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved. Disclaimer and Forward-Looking Statement Information This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, the Company's expectations with respect to the timing of the relisting of its common stock on a national securities exchange. These forward-looking statements are based on the current beliefs and expectations of the Company's management with respect to future events, only speak as of the date that they are made, and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "continue," "can," "may," "look forward," "aims," "hopes," and "seeks" and similar terms, although not all forward-looking statements contain such words or expressions. Actual results could differ significantly from those set forth in the forward-looking statements. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, among others: a further material delay in the Company's financial reporting or ability to hold an annual meeting of stockholders; an inability of the Company to timely prepare its delinquent financial statements; unanticipated factors or factors that the Company currently believes will not cause further delay; the Company's remediation efforts and preparation of financial statements or other factors that could cause additional delay or adjustments; the possibility that ongoing remediation work or the audit of the Company's financial statements for the fiscal year ended December 31, 2023 or the fiscal year ended December 31, 2024 may identify additional errors and material weaknesses or other deficiencies in the Company's accounting practices; the likelihood that the control deficiencies identified or that may be identified in the future will result in additional material weaknesses in the Company's internal control over financial reporting; risks relating to the Company's voluntary disclosure to the SEC of certain information relating to the investigation by the Audit Committee of the Company's Board of Directors, the SEC's investigation, and the additional information the Company has continued to provide to the SEC based on discussions with the SEC; changes in the financial condition of the markets that the Company serves; the Company's ability to hire qualified individuals to serve in senior leadership roles on a permanent basis, including a chief financial officer; and other factors contained in the "Risk Factors" section and elsewhere in the Company's filings with the SEC from time to time, including, but not limited to, the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The Company does not undertake to update any forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes over time, except as required by law. View source version on Contacts For more information contact: Investors:Jenny Media:Rick Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
11 minutes ago
- Yahoo
Top 5 jobs safe from AI
AI is likely coming for millions of jobs, but Microsoft says these 5 are basically robot-proof: Phlebotomists, nursing assistants, Hazardous Materials Removal Workers, Helpers, Painters, Plasterers, Embalmers Video produced by Yahoo Finance Video Transcript AI is likely coming for millions of jobs, but Microsoft says that these five are likely robot proof. Number one, phlebotomists. That's the medical professional who draws your blood. AI might be booking your appointments, but it's not picking up a needle. Number two, nursing assistants. These workers provide hands-on care, bedpans, bathing, feeding. These are not exactly tasks you're gonna outsource to ChatGPT. Number three, hazardous material removal workers, removing asbestos, lead, or radioactive waste. It is dangerous work and right now something that only humans can be trusted with. Number four is helpers, painters, plasters. This is anything that's hands-on work. So a robot might be able to design your color palette, but picking up a paintbrush, that's not happening, not yet. And finally, the last of the top five jobs, safe from AI embalmers. Preparing bodies for a funeral is personal and delicate work, and right now it is still human only. So if you're in one of these jobs, you might just have more security than the rest of us in this age of AI.
Associated Press
12 minutes ago
- Associated Press
At least 600 CDC employees are getting final termination notices, union says
NEW YORK (AP) — At least 600 employees of the Centers for Disease Control and Prevention are receiving permanent termination notices in the wake of a recent court decision that protected some CDC employees from layoffs but not others. The notices went out this week and many people have not yet received them, according to the American Federation of Government Employees, which represents more than 2,000 dues-paying members at CDC. Officials with the U.S. Department of Health and Human Services did not immediately respond to a request for comment. AFGE officials said they are aware of at least 600 employees being cut. But 'due to a staggering lack of transparency from HHS,' the union hasn't received formal notices of who is being laid off,' the federation said in a statement on Wednesday. The permanent cuts include about 100 people who worked in violence prevention. Some employees noted those cuts come less than two weeks after a man fired at least 180 bullets into the CDC's campus and killed a police officer. 'The irony is devastating: The very experts trained to understand, interrupt and prevent this kind of violence were among those whose jobs were eliminated,' some of the affected employees wrote in a blog post last week. On April 1, the HHS officials sent layoff notices to thousands of employees at the CDC and other federal health agencies, part of a sweeping overhaul designed to vastly shrink the agencies responsible for protecting and promoting Americans' health. Many have been on administrative leave since then — paid but not allowed to work — as lawsuits played out. A federal judge in Rhode Island last week issued a preliminary ruling that protected employees in several parts of the CDC, including groups dealing with smoking, reproductive health, environmental health, workplace safety, birth defects and sexually transmitted diseases. But the ruling did not protect other CDC employees, and layoffs are being finalized across other parts of the agency, including in the freedom of information office. The terminations were effective as of Monday, employees were told. Affected projects included work to prevent rape, child abuse and teen dating violence. The laid-off staff included people who have helped other countries to track violence against children — an effort that helped give rise to an international conference in November at which countries talked about setting violence-reduction goals. 'There are nationally and internationally recognized experts that will be impossible to replace,' said Tom Simon, the retired senior director for scientific programs at the CDC's Division of Violence Prevention. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
